Global Obesity Intervention Devices Market

Obesity Intervention Devices Comprehensive Study by Type (Gastric Bands, Electrical Emptying System, Gastric Balloon, Gastric stimulation system), End User (Hospitals, Clinics) Players and Region - Global Market Outlook to 2028

Obesity Intervention Devices Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Obesity Intervention Devices Market Overview:
Medical devices used to manage obesity are called obesity intervention devices. These tools are meant to help you lose weight by lowering your calorie intake or changing the way your body breaks down food. Weight loss that ameliorates or alleviates type 2 diabetes leads to the approval of obesity intervention devices. Gastric bands, gastric balloons, and gastric stimulation systems are examples of obesity intervention techniques. The increasing prevalence of obesity is expected to propel the growth of the obesity intervention devices market.

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Increasing Government Initiatives for Appropriate Management for Obese Patients

Market Growth Drivers:
Increase in the Prevalence of Obesity and Increasing Number of Product Launches for Obesity Intervention Device Drugs

Challenges:
Increase in Awareness among the People Regarding the Adverse Effects of Obesity

Restraints:
High Production Costs and Limited Financial Support for Surgery and High Cost of Available Obesity Treatment Alternatives

Opportunities:
Increasing Need For Continuous Improvement in Technology

Competitive Landscape:
Obesity Intervention Devices is a fragmented market due to the presence of a large number of established competitors. The key players are highly focused on developing and innovating new strategies to maintain their market position and customer base. The companies are also planning strategic activities like partnerships, collaboration, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge
Some of the key players profiled in the report are Apollo Endosurgery (United States), Cousin Surgery (France), Spatz FGIA Inc. (United States), GI Dynamics (United States), Abbvie Inc. (Allergan) (United States), Endalis Laboratoire (France), Allurion Technologies, Inc. (United States), A.M.I. GmbH (Austria), ReShape Lifesciences Inc. (United States) and Johnson & Johnson (United States). Additionally, following companies can also be profiled that are part of our coverage like Medtronic, EnteroMedics and Aspire Bariatrics. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Obesity Intervention Devices market.

Latest Market Insights:
In May 2020, research-based global biopharmaceutical company AbbVie (NYSE: ABBV) acquired Allergan plc. after obtaining regulatory approvals from all government authorities and Irish High Court approvals required for the transaction agreement. A diversified leader in many important therapeutic categories with both market and pipeline assets and financial strength.



What Can be Explored with the Obesity Intervention Devices Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Obesity Intervention Devices Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Obesity Intervention Devices
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Obesity Intervention Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Obesity Intervention Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Research and Development (R&D) companies, Government Agencies and End User Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Gastric Bands
  • Electrical Emptying System
  • Gastric Balloon
  • Gastric stimulation system
By End User
  • Hospitals
  • Clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Prevalence of Obesity
      • 3.2.2. Increasing Number of Product Launches for Obesity Intervention Device Drugs
    • 3.3. Market Challenges
      • 3.3.1. Increase in Awareness among the People Regarding the Adverse Effects of Obesity
    • 3.4. Market Trends
      • 3.4.1. Increasing Government Initiatives for Appropriate Management for Obese Patients
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Obesity Intervention Devices, by Type, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Obesity Intervention Devices (Value)
      • 5.2.1. Global Obesity Intervention Devices by: Type (Value)
        • 5.2.1.1. Gastric Bands
        • 5.2.1.2. Electrical Emptying System
        • 5.2.1.3. Gastric Balloon
        • 5.2.1.4. Gastric stimulation system
      • 5.2.2. Global Obesity Intervention Devices by: End User (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
      • 5.2.3. Global Obesity Intervention Devices Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Obesity Intervention Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Apollo Endosurgery (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cousin Surgery (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Spatz FGIA Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GI Dynamics (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Abbvie Inc. (Allergan) (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Endalis Laboratoire (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Allurion Technologies, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. A.M.I. GmbH (Austria)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. ReShape Lifesciences Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Johnson & Johnson (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Obesity Intervention Devices Sale, by Type, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Obesity Intervention Devices (Value)
      • 7.2.1. Global Obesity Intervention Devices by: Type (Value)
        • 7.2.1.1. Gastric Bands
        • 7.2.1.2. Electrical Emptying System
        • 7.2.1.3. Gastric Balloon
        • 7.2.1.4. Gastric stimulation system
      • 7.2.2. Global Obesity Intervention Devices by: End User (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
      • 7.2.3. Global Obesity Intervention Devices Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Obesity Intervention Devices: by Type(USD Million)
  • Table 2. Obesity Intervention Devices Gastric Bands , by Region USD Million (2017-2022)
  • Table 3. Obesity Intervention Devices Electrical Emptying System , by Region USD Million (2017-2022)
  • Table 4. Obesity Intervention Devices Gastric Balloon , by Region USD Million (2017-2022)
  • Table 5. Obesity Intervention Devices Gastric stimulation system , by Region USD Million (2017-2022)
  • Table 6. Obesity Intervention Devices: by End User(USD Million)
  • Table 7. Obesity Intervention Devices Hospitals , by Region USD Million (2017-2022)
  • Table 8. Obesity Intervention Devices Clinics , by Region USD Million (2017-2022)
  • Table 9. South America Obesity Intervention Devices, by Country USD Million (2017-2022)
  • Table 10. South America Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 11. South America Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 12. Brazil Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 13. Brazil Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 14. Argentina Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 15. Argentina Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 16. Rest of South America Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 17. Rest of South America Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 18. Asia Pacific Obesity Intervention Devices, by Country USD Million (2017-2022)
  • Table 19. Asia Pacific Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 20. Asia Pacific Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 21. China Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 22. China Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 23. Japan Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 24. Japan Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 25. India Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 26. India Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 27. South Korea Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 28. South Korea Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 29. Taiwan Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 30. Taiwan Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 31. Australia Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 32. Australia Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 33. Rest of Asia-Pacific Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 34. Rest of Asia-Pacific Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 35. Europe Obesity Intervention Devices, by Country USD Million (2017-2022)
  • Table 36. Europe Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 37. Europe Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 38. Germany Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 39. Germany Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 40. France Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 41. France Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 42. Italy Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 43. Italy Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 44. United Kingdom Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 45. United Kingdom Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 46. Netherlands Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 47. Netherlands Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 48. Rest of Europe Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 49. Rest of Europe Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 50. MEA Obesity Intervention Devices, by Country USD Million (2017-2022)
  • Table 51. MEA Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 52. MEA Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 53. Middle East Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 54. Middle East Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 55. Africa Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 56. Africa Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 57. North America Obesity Intervention Devices, by Country USD Million (2017-2022)
  • Table 58. North America Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 59. North America Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 60. United States Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 61. United States Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 62. Canada Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 63. Canada Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 64. Mexico Obesity Intervention Devices, by Type USD Million (2017-2022)
  • Table 65. Mexico Obesity Intervention Devices, by End User USD Million (2017-2022)
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Obesity Intervention Devices: by Type(USD Million)
  • Table 77. Obesity Intervention Devices Gastric Bands , by Region USD Million (2023-2028)
  • Table 78. Obesity Intervention Devices Electrical Emptying System , by Region USD Million (2023-2028)
  • Table 79. Obesity Intervention Devices Gastric Balloon , by Region USD Million (2023-2028)
  • Table 80. Obesity Intervention Devices Gastric stimulation system , by Region USD Million (2023-2028)
  • Table 81. Obesity Intervention Devices: by End User(USD Million)
  • Table 82. Obesity Intervention Devices Hospitals , by Region USD Million (2023-2028)
  • Table 83. Obesity Intervention Devices Clinics , by Region USD Million (2023-2028)
  • Table 84. South America Obesity Intervention Devices, by Country USD Million (2023-2028)
  • Table 85. South America Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 86. South America Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 87. Brazil Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 88. Brazil Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 89. Argentina Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 90. Argentina Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 91. Rest of South America Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 92. Rest of South America Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 93. Asia Pacific Obesity Intervention Devices, by Country USD Million (2023-2028)
  • Table 94. Asia Pacific Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 95. Asia Pacific Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 96. China Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 97. China Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 98. Japan Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 99. Japan Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 100. India Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 101. India Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 102. South Korea Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 103. South Korea Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 104. Taiwan Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 105. Taiwan Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 106. Australia Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 107. Australia Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 108. Rest of Asia-Pacific Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 109. Rest of Asia-Pacific Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 110. Europe Obesity Intervention Devices, by Country USD Million (2023-2028)
  • Table 111. Europe Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 112. Europe Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 113. Germany Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 114. Germany Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 115. France Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 116. France Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 117. Italy Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 118. Italy Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 119. United Kingdom Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 120. United Kingdom Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 121. Netherlands Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 122. Netherlands Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 123. Rest of Europe Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 124. Rest of Europe Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 125. MEA Obesity Intervention Devices, by Country USD Million (2023-2028)
  • Table 126. MEA Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 127. MEA Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 128. Middle East Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 129. Middle East Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 130. Africa Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 131. Africa Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 132. North America Obesity Intervention Devices, by Country USD Million (2023-2028)
  • Table 133. North America Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 134. North America Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 135. United States Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 136. United States Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 137. Canada Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 138. Canada Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 139. Mexico Obesity Intervention Devices, by Type USD Million (2023-2028)
  • Table 140. Mexico Obesity Intervention Devices, by End User USD Million (2023-2028)
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Obesity Intervention Devices: by Type USD Million (2017-2022)
  • Figure 5. Global Obesity Intervention Devices: by End User USD Million (2017-2022)
  • Figure 6. South America Obesity Intervention Devices Share (%), by Country
  • Figure 7. Asia Pacific Obesity Intervention Devices Share (%), by Country
  • Figure 8. Europe Obesity Intervention Devices Share (%), by Country
  • Figure 9. MEA Obesity Intervention Devices Share (%), by Country
  • Figure 10. North America Obesity Intervention Devices Share (%), by Country
  • Figure 11. Global Obesity Intervention Devices share by Players 2022 (%)
  • Figure 12. Global Obesity Intervention Devices share by Players (Top 3) 2022(%)
  • Figure 13. Global Obesity Intervention Devices share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Apollo Endosurgery (United States) Revenue, Net Income and Gross profit
  • Figure 16. Apollo Endosurgery (United States) Revenue: by Geography 2022
  • Figure 17. Cousin Surgery (France) Revenue, Net Income and Gross profit
  • Figure 18. Cousin Surgery (France) Revenue: by Geography 2022
  • Figure 19. Spatz FGIA Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Spatz FGIA Inc. (United States) Revenue: by Geography 2022
  • Figure 21. GI Dynamics (United States) Revenue, Net Income and Gross profit
  • Figure 22. GI Dynamics (United States) Revenue: by Geography 2022
  • Figure 23. Abbvie Inc. (Allergan) (United States) Revenue, Net Income and Gross profit
  • Figure 24. Abbvie Inc. (Allergan) (United States) Revenue: by Geography 2022
  • Figure 25. Endalis Laboratoire (France) Revenue, Net Income and Gross profit
  • Figure 26. Endalis Laboratoire (France) Revenue: by Geography 2022
  • Figure 27. Allurion Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Allurion Technologies, Inc. (United States) Revenue: by Geography 2022
  • Figure 29. A.M.I. GmbH (Austria) Revenue, Net Income and Gross profit
  • Figure 30. A.M.I. GmbH (Austria) Revenue: by Geography 2022
  • Figure 31. ReShape Lifesciences Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. ReShape Lifesciences Inc. (United States) Revenue: by Geography 2022
  • Figure 33. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 34. Johnson & Johnson (United States) Revenue: by Geography 2022
  • Figure 35. Global Obesity Intervention Devices: by Type USD Million (2023-2028)
  • Figure 36. Global Obesity Intervention Devices: by End User USD Million (2023-2028)
  • Figure 37. South America Obesity Intervention Devices Share (%), by Country
  • Figure 38. Asia Pacific Obesity Intervention Devices Share (%), by Country
  • Figure 39. Europe Obesity Intervention Devices Share (%), by Country
  • Figure 40. MEA Obesity Intervention Devices Share (%), by Country
  • Figure 41. North America Obesity Intervention Devices Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Apollo Endosurgery (United States)
  • Cousin Surgery (France)
  • Spatz FGIA Inc. (United States)
  • GI Dynamics (United States)
  • Abbvie Inc. (Allergan) (United States)
  • Endalis Laboratoire (France)
  • Allurion Technologies, Inc. (United States)
  • A.M.I. GmbH (Austria)
  • ReShape Lifesciences Inc. (United States)
  • Johnson & Johnson (United States)
Additional players considered in the study are as follows:
Medtronic , EnteroMedics , Aspire Bariatrics
Select User Access Type

Key Highlights of Report


May 2023 245 Pages 73 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Obesity Intervention Devices Market Quantitative research analysis
Global Obesity Intervention Devices Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Obesity Intervention Devices market are Apollo Endosurgery (United States), Cousin Surgery (France), Spatz FGIA Inc. (United States), GI Dynamics (United States), Abbvie Inc. (Allergan) (United States), Endalis Laboratoire (France), Allurion Technologies, Inc. (United States), A.M.I. GmbH (Austria), ReShape Lifesciences Inc. (United States) and Johnson & Johnson (United States), to name a few.
"Increasing Government Initiatives for Appropriate Management for Obese Patients" is seen as one of major influencing trends for Obesity Intervention Devices Market during projected period 2022-2028.
Gastric Bands segment in Global market to hold robust market share owing to "Increase in the Prevalence of Obesity ".

Know More About Global Obesity Intervention Devices Market Report?

Have a Query? Click Here

Other Related Reports

Healthcare Simulation- Comprehensive Study by Application (Laparoscopic Surgical Simulator, Gynaecology Simulator, Cardiovascular Simulators, Orthopaedic Simulators, Spine Surgical Simulators, Others...
$ 3800
Medical Robotics- Comprehensive Study by Type (Surgical Robots, Rehabilitation Robots, Hospital and Pharmacy Robots, Bio Robotics, Non-invasive Radio Surgery Robots, Telepresence Robots, Medical Tran...
$ 3800
3D Dental Scanner- Comprehensive Study by Type (Desktop or Laboratory 3D Dental Scanners, Intraoral 3D Dental Scanners, Cone Beam Computerized Tomography (CBCT)), Scanner Type (Light Scanner, Laser S...
$ 3800
Casting Tape- Comprehensive Study by Application (Fracture Management, Post-Surgery Support, Sprains and Strains Treatment, Others), End Users (Hospitals And Clinics, Ambulatory Center, Orthopaedics ...
$ 3800